Press Release Summary:
Featuring stand-alone desktop design, ResurFX System includes CoolScan™ technology, which ensures precise and safe energy delivery with continuous contact cooling. Customized treatment parameters allow aesthetic professionals to choose from more than 600 combinations of shape, size, density, and energy delivery, and customize their treatments. Unlike other fractional technologies, ResurFX needs only one pass to be effective.
Original Press Release:
Lumenis Further Expands Its Product Line with a New ResurFX(TM)* System - A True Fractional Non-Ablative Stand-Alone Skin Resurfacing Solution
More Aesthetic Practitioners Will be Able to Offer Their Patients the Latest Technology in Non-Ablative Skin Resurfacing
YOKNEAM, Israel -- Lumenis Ltd. (Nasdaq:LMNS), the world's largest energy-based medical company for aesthetic, surgical and ophthalmology applications, announced today the launch of the new ResurFX laser system for fractional non-ablative skin resurfacing treatments. This new ResurFX system is a stand-alone desktop solution with sleek design and user interface, which leverages on the superb technology and builds upon the successful launch of ResurFX module for the M22(TM) multi-application platform. The system debuts at the International Master Course on Aging Skin (IMCAS) Annual World Congress 2015, taking place in Paris, France from January 29 to February 1, 2015. Lumenis will be exhibiting at booth A11 throughout the meeting.
The new ResurFX system offers advanced features to improve efficacy and patient comfort, making it an ideal addition for each practice wanting to expand its non-ablative treatment offering. Lumenis' CoolScan(TM) technology ensures precise and safe energy delivery with continuous contact cooling, while the ResurFX system's customized treatment parameters allow aesthetic professionals to choose from more than 600 combinations of shape, size, density and energy delivery, and customize their treatments. Unlike other fractional technologies, ResurFX needs only one pass to be effective, saving practices time and protecting the patient's skin. With no disposables, the new ResurFX is also cost-effective for growing practices.
This extension of our offerings in the field of skin resurfacing will allow physicians to choose the best solution for their practice:
-- A full multi application M22 platform with ResurFX, which also features the Lumenis Gold Standard IPL with OPT, Long Pulsed Nd:YAG and Q-Switched Nd:YAG
-- A stand-alone desktop version of the ResurFX with a compact sleek design and user interface
"We have seen such a dramatic rise in fractional non-ablative skin resurfacing because the procedure provides excellent results without the long downtime associated with other cosmetic procedures," said Dr. Matteo Tretti Clementoni of Istituto Dermatologico Europeo. "ResurFX is the leading solution in this space because it provides the best balance of efficacy and patient convenience - some of my patients are even coming in for ResurFX treatment as a 'lunch-time' skin rejuvenation procedure."
In addition to introducing the new ResurFX, Lumenis will also be participating in a lecture series for attendees at IMCAS. Lumenis CEO Tzipi Ozer-Armon will deliver a presentation about the growth in demand for aesthetic products and services in the Asia-Pacific market, particularly China.
"The growing middle class in China and our 20 years of operational experience in the market propelled our continuous double digit growth in the APAC region," said Ms. Ozer-Armon. "We are honored to be speaking about this topic at IMCAS and look forward to working with aesthetic professionals across the globe to bring the new ResurFX system to patients."
Lumenis (Nasdaq:LMNS) is a global leader in the field of minimally-invasive clinical solutions for the Surgical, Ophthalmology and Aesthetic markets, and is a world-renowned expert in developing and commercializing innovative energy-based technologies, including Laser, Intense Pulsed Light (IPL) and Radio-Frequency (RF). For nearly 50 years, Lumenis' ground-breaking products have redefined medical treatments and have set numerous technological and clinical gold-standards. Lumenis has successfully created solutions for previously untreatable conditions, as well as designed advanced technologies that have revolutionized existing treatment methods in each and every one of the verticals we operate in. For more information visit: www.lumenis.com